Mary Ann Bonilla

4.6k total citations
47 papers, 3.3k citations indexed

About

Mary Ann Bonilla is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Mary Ann Bonilla has authored 47 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 26 papers in Oncology and 19 papers in Immunology. Recurrent topics in Mary Ann Bonilla's work include Blood disorders and treatments (33 papers), Neutropenia and Cancer Infections (24 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Mary Ann Bonilla is often cited by papers focused on Blood disorders and treatments (33 papers), Neutropenia and Cancer Infections (24 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Mary Ann Bonilla collaborates with scholars based in United States, Germany and Canada. Mary Ann Bonilla's co-authors include Karl Welte, David C. Dale, Audrey Anna Bolyard, Laurence A. Boxer, Cornelia Zeidler, Janice Gabrilove, George Kannourakis, Nai‐Kong V. Cheung, L M Souza and Brian H. Kushner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Mary Ann Bonilla

46 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ann Bonilla United States 22 1.7k 1.3k 1.3k 699 609 47 3.3k
Russell K. Brynes United States 35 397 0.2× 755 0.6× 1.1k 0.8× 1.0k 1.4× 227 0.4× 105 3.3k
Alfred P. Gillio United States 21 673 0.4× 712 0.6× 1.2k 0.9× 1.1k 1.5× 115 0.2× 49 2.7k
Dagmar Oette United States 10 454 0.3× 562 0.4× 1.4k 1.1× 1.3k 1.9× 149 0.2× 13 2.6k
A. Lindemann Germany 32 467 0.3× 1.8k 1.4× 1.1k 0.9× 892 1.3× 65 0.1× 87 3.3k
M A Moore United States 18 357 0.2× 1.0k 0.8× 855 0.7× 689 1.0× 71 0.1× 37 2.3k
Javier Briones Spain 35 322 0.2× 1.7k 1.3× 1.9k 1.5× 1.0k 1.5× 316 0.5× 161 4.5k
AE von dem Borne Netherlands 37 913 0.5× 1.6k 1.3× 404 0.3× 2.5k 3.5× 63 0.1× 72 4.4k
Carmella van de Ven United States 31 386 0.2× 1.1k 0.8× 891 0.7× 1.1k 1.6× 107 0.2× 151 2.9k
Hugo Castro‐Malaspina United States 36 389 0.2× 1.9k 1.5× 1.7k 1.4× 3.3k 4.7× 176 0.3× 153 5.1k
Bruce Patterson Canada 32 183 0.1× 972 0.8× 1.2k 0.9× 919 1.3× 369 0.6× 59 3.7k

Countries citing papers authored by Mary Ann Bonilla

Since Specialization
Citations

This map shows the geographic impact of Mary Ann Bonilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Bonilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Bonilla more than expected).

Fields of papers citing papers by Mary Ann Bonilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Bonilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Bonilla. The network helps show where Mary Ann Bonilla may publish in the future.

Co-authorship network of co-authors of Mary Ann Bonilla

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Bonilla. A scholar is included among the top collaborators of Mary Ann Bonilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Bonilla. Mary Ann Bonilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dale, David C., Audrey Anna Bolyard, James A. Shannon, et al.. (2022). Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor. Blood Advances. 6(13). 3861–3869. 11 indexed citations
3.
Makaryan, Vahagn, Cornelia Zeidler, Audrey Anna Bolyard, et al.. (2014). The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Current Opinion in Hematology. 22(1). 3–11. 100 indexed citations
4.
Dale, David C., et al.. (2013). Barth Syndrome and Neutropenia. Blood. 122(21). 3465–3465. 1 indexed citations
5.
Boxer, Laurence A., Audrey Anna Bolyard, Blanche P. Alter, et al.. (2010). Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment.. Blood. 116(21). 1490–1490. 5 indexed citations
6.
Rosenberg, Philip S., Cornelia Zeidler, Audrey Anna Bolyard, et al.. (2010). Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy. British Journal of Haematology. 150(2). 196–199. 150 indexed citations
7.
Dale, David C., Audrey Anna Bolyard, Beate Schwinzer, et al.. (2006). The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. PubMed. 3(4). 220–231. 98 indexed citations
8.
Cham, Bonnie, Mary Ann Bonilla, & Jerry A. Winkelstein. (2002). Neutropenia associated with primary immunodeficiency syndromes. Seminars in Hematology. 39(2). 107–112. 54 indexed citations
9.
Freedman, Melvin H., Mary Ann Bonilla, Carol Fier, et al.. (2000). Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.. Blood. 96(2). 429–36. 156 indexed citations
10.
Freedman, Melvin H., Mary Ann Bonilla, Carol Fier, et al.. (1999). THE INTERNATIONAL REGISTRY ON SEVERE CHRONIC NEUTROPENIA (SCNIR). Pediatric Research. 45(6). 943–943. 1 indexed citations
11.
Freedman, Melvin H., Mary Ann Bonilla, Carol Fier, et al.. (1999). IMPROVED SURVIVAL FROM GRANULOCYTE-COLONY STIMULATING FACTOR THERAPY FOR CONGENITAL NEUTROPENIA UNMASKS PREDISPOSITION TO MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA. Pediatric Research. 45(6). 942–942. 3 indexed citations
12.
Freedman, Melvin H., Mary Ann Bonilla, Carol Fier, et al.. (1999). THE INTERNATIONAL REGISTRY ON SEVERE CHRONIC NEUTROPENIA (SCNIR). Pediatric Research. 45(6). 943–943. 1 indexed citations
13.
Kushner, Brian H., Nai‐Kong V. Cheung, Michael P. LaQuaglia, et al.. (1996). Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.. Journal of Clinical Oncology. 14(2). 373–381. 82 indexed citations
14.
Kushner, Brian H., N K Cheung, Michael P. LaQuaglia, et al.. (1996). International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.. Journal of Clinical Oncology. 14(7). 2174–2180. 36 indexed citations
15.
Kushner, BH, Michael P. LaQuaglia, Mary Ann Bonilla, et al.. (1994). Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.. Journal of Clinical Oncology. 12(12). 2607–2613. 134 indexed citations
16.
Bonilla, Mary Ann & Nai‐Kong V. Cheung. (1994). Clinical Progress in Neuroblastoma. Cancer Investigation. 12(6). 644–653. 11 indexed citations
17.
LaQuaglia, Michael P., Brian H. Kushner, Glenn Heller, et al.. (1994). Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome. Journal of Pediatric Surgery. 29(8). 1162–1166. 58 indexed citations
18.
Bonilla, Mary Ann, David C. Dale, Cornelia Zeidler, et al.. (1994). Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias. British Journal of Haematology. 88(4). 723–730. 164 indexed citations
19.
Cheung, N K, Irene Y. Cheung, Adela Cañete, et al.. (1994). Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.. PubMed. 54(8). 2228–33. 66 indexed citations
20.
Welte, Karl, Mary Ann Bonilla, Alfred P. Gillio, et al.. (1987). Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.. The Journal of Experimental Medicine. 165(4). 941–948. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell K. Brynes Breakdown of academic impact, for papers by Alfred P. Gillio Breakdown of academic impact, for papers by Dagmar Oette Breakdown of academic impact, for papers by A. Lindemann Breakdown of academic impact, for papers by M A Moore Breakdown of academic impact, for papers by Javier Briones Breakdown of academic impact, for papers by AE von dem Borne Breakdown of academic impact, for papers by Carmella van de Ven Breakdown of academic impact, for papers by Hugo Castro‐Malaspina Breakdown of academic impact, for papers by Bruce Patterson
Rankless by CCL
2026